National Centre for Mesothelioma Research at the Great Exhibition Road Festival

Words By Maija Maskuniitty, NCMR Centre Manager.

“The National Centre for Mesothelioma Research (NCMR) was delighted to take part in the first ever Great Exhibition Road Festival on the last weekend of June 2019.

The Festival – a celebration of curiosity, discovery and exploration – was attended by more than 45,000 members of the public to explore and learn about the research carried out at Imperial College London. It was therefore an excellent opportunity to raise awareness of mesothelioma and asbestos, and to share NCMR’s mesothelioma research with the public.

We teamed up with Mesothelioma UK, Royal Brompton and Royal Marsden Hospitals, Asbestos Victims Support Groups Forum UK, and mesothelioma patients and carers to put together interactive activities which explored aspects of mesothelioma and asbestos. Most people who visited our festival stand – called How does asbestos cause cancer? – did not know what mesothelioma is or how it’s caused, and many were surprised by how widely asbestos is still used in some countries. We therefore tried to ensure that the people we spoke
to left the festival well informed.

Our activities included a timeline exploring the history of asbestos in the UK – based on the blog post The Asbestos Story: a tale of public health and politics – and an audio installation called My Mesothelioma Story with interviews from wonderful patient and carer volunteers. The interviews will soon be available to listen online on our website. Festival attendees also had the opportunity to examine healthy lung tissue and mesothelioma tissue through a microscope, and Meso UK’s Tommy the Torso was a big hit especially with the younger audience.

For a disease like mesothelioma awareness is vital, and events such as the Great Exhibition Road Festival offer a great opportunity to spread the word about mesothelioma and asbestos. Huge thanks to all our collaborators –
it was wonderful to work together for this important cause, and we look
forward to more public engagement events in the future.”

Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of...

Mesothelioma UK partners with Healthinote

Mesothelioma UK has joined Healthinote, an online digital platform allowing doctors, nurses and pharmacists to find and share reliable health information with their patients. Used by over 3,000 GP practices in the UK, Heathinote enables people to be given an...

New Chemotherapy Booklet

Our new booklet Chemotherapy for Mesothelioma addresses key questions people with mesothelioma may have if they are offered chemotherapy. “Whether to accept chemotherapy is not always a straightforward decision for people with mesothelioma. Our new booklet can help...

Mesothelioma UK appoints new Head of Nursing

Leah Taylor has been appointed as the new Head of Nursing for Mesothelioma UK. In this role, Leah will work closely with the charity’s operational team and trustees, and will provide strategic leadership of the charity’s UK network of 34 Clinical Nurse Specialists....

PIF TICK certification for our patient information

We know how overwhelming a diagnosis of mesothelioma can be, and how good written information can play a vital part in helping people make informed choices. This is why we’re so pleased to have been recertified under the PIF TICK scheme, demonstrating our commitment...